SCIENCE OF
POSSIBILITY
At Vertex, we invest in scientific innovation to create transformative medicines for people with serious diseases.
We report third quarter 2024 financial results
Vertex to share new data from multiple investigational kidney disease programs at the 2024 American Society of Nephrology Kidney Week Congress
We announced that we will present pivotal Phase 3 data about our investigational pain program at the annual meeting of the American Society of Anesthesiologists
We are presenting new data on our cystic fibrosis medicines at the 2024 North American Cystic Fibrosis Conference
We've announced the acceptance of the New Drug Application submission to the FDA for our investigational acute pain medication
Working at Vertex
Our company is built on an inclusive culture that brings together the best and brightest in every field striving for one goal: to improve the lives of people with serious diseases.
Find a Vertex clinical trial
Volunteers who participate in clinical trials
help make new medicines a reality.
Featured stories
Our annual Global Week of Service is a longstanding tradition and opportunity for Vertexians around the world to give back to the communities where we live and work. Find out how we made an impact in our 16th year.
Hear more from five individuals living with type 1 diabetes about how their diagnosis and management journey has impacted them and their loved ones.
From recent high school graduates to those pursuing advanced degrees, this year’s Vertex Foundation Scholars are chasing their dreams.
Our annual Global Week of Service is a longstanding tradition and opportunity for Vertexians around the world to give back to the communities where we live and work. Find out how we made an impact in our 16th year.
Hear more from five individuals living with type 1 diabetes about how their diagnosis and management journey has impacted them and their loved ones.
From recent high school graduates to those pursuing advanced degrees, this year’s Vertex Foundation Scholars are chasing their dreams.
